| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0001600145-22-000005 | Mar 31st, 2022 12:00AM | May 20th, 2022 12:00AM | May 20th, 2022 12:00AM | Van Hulzen Asset Management, LLC | 1600145 | INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 404 | 6600 | SH | SOLE | 0 | 0 | 0 | 6600 | May 21st, 2022 01:10AM | May 21st, 2022 01:10AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0001145443-22-000169 | Mar 31st, 2022 12:00AM | May 20th, 2022 12:00AM | May 20th, 2022 12:00AM | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 928047 | INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 1999 | 32670 | SH | DFND | 1,2,5 | 0 | 0 | 32670 | May 21st, 2022 01:09AM | May 21st, 2022 01:09AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0000950123-22-006648 | Mar 31st, 2022 12:00AM | May 20th, 2022 12:00AM | May 20th, 2022 12:00AM | INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 942257 | INTRA-CELLULAR THERAPIES | COM | 46116X101 | 20930 | 50956 | SH | SOLE | 50956 | 0 | 0 | May 21st, 2022 01:08AM | May 21st, 2022 01:08AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | Intra Cellular Therapies Inc | Equity | 46116X101 | 1231938 | 20133 | SH | DFND | 1 | 0 | 20133 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 2166 | 35400 | SH | Put | DFND | 2 | 35400 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 4528 | 74000 | SH | Call | DFND | 2 | 0 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 639 | 10446 | SH | DFND | 2 | 10446 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 1328 | 21704 | SH | DFND | 1 | 21704 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0001533964-22-000006 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | Virtu Financial LLC | 1533964 | INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 1049 | 17143 | SH | DFND | 5 | 17143 | 0 | 0 | May 18th, 2022 01:12AM | May 18th, 2022 01:12AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:itci | nasdaq:itci Shareholders | 13F-HR | 0001085146-22-002205 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | Beacon Pointe Advisors, LLC | 1744317 | INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 215 | 3518 | SH | SOLE | 3518 | 0 | 0 | May 18th, 2022 01:11AM | May 18th, 2022 01:11AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology |